Targeting rapidly cycling receptors CD2 and CD7 increases nanoparticle delivery to primary CD4(+) T cells.

Authors: Cevaal PM, Ali A, Doerflinger M, Cortez-Jugo C, Tan A, Liu H, Chen MZ, Wang L, Dayton M, Mackiewicz L, Kan S, Faria M, Gubser C, Lafleur RPM, De Rose R, Johnston APR, Caruso F, Roche M, Symons J, Lewin SR

Journal: Nature communications